- Home
- NVCT vs PCT Comparison
NVCT vs PCT Comparison
Compare NVCT & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCT | PCT |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.1M | 556.5M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NVCT | PCT |
|---|---|---|
| Price | $20.07 | $1.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $35.40 | $10.60 |
| AVG Volume (30 Days) | 164.7K | ★ 6.8M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,355,000.00 |
| Revenue This Year | N/A | $269.48 |
| Revenue Next Year | N/A | $262.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.77 | $2.59 |
| 52 Week High | $29.28 | $14.20 |
Technical Indicators
Market Signals| Indicator | NVCT | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.92 | 18.91 |
| Support Level | $19.78 | N/A |
| Resistance Level | $22.56 | $6.23 |
| Average True Range (ATR) | 1.59 | 0.34 |
| MACD | 0.10 | -0.04 |
| Stochastic Oscillator | 65.80 | 0.52 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About PCT PureCycle Technologies Inc.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.